Related Experiment Video

Updated: Jun 26, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell

C Salvarani1, C Della Bella, L Cimino

  • 1Unità Operativa di Reumatologia, Arcispedale S. Maria Nuova, Reggio Emilia, Italy. salvarani.carlo@asmn.re.it

Rheumatology (Oxford, England)
|December 26, 2008
PubMed

Insights

In Giant Cell Arteritis (GCA), hypertension and prior ischemic heart disease increase the risk of severe cranial ischemic events (CIEs). A low inflammatory response also predicts higher CIE occurrence.

Area of Science:

  • Rheumatology
  • Neurology
  • Cardiology

Background:

  • Giant Cell Arteritis (GCA) is a systemic vasculitis affecting large arteries.
  • Cranial Ischemic Events (CIEs) are serious complications of GCA.
  • Understanding risk factors for CIEs in GCA is crucial for patient management.

Purpose of the Study:

  • To investigate the role of cardiovascular risk factors in GCA.
  • To assess the impact of carotid atherosclerosis on CIEs in GCA patients.
  • To evaluate the effect of anti-platelet/anti-coagulant therapy on CIEs in GCA.

Main Methods:

  • Retrospective analysis of 180 biopsy-proven GCA patients.
  • Data collection included demographics, clinical features, and laboratory results.
  • Evaluation of cardiovascular risk factors, anti-platelet/anti-coagulant use, and carotid atherosclerosis.

Main Results:

  • Patients with CIEs had less frequent systemic signs/symptoms and lower ESR/CRP levels at diagnosis.
  • Hypertension and ischemic heart disease were more prevalent in patients with CIEs.
  • Anti-platelet/anti-coagulant therapy and ischemic heart disease were associated with increased CIE risk.

Conclusions:

  • Hypertension is a significant predictor of severe CIEs in GCA.
  • A history of ischemic heart disease is associated with a higher risk of CIEs.
  • A low inflammatory response at diagnosis may indicate an increased risk for CIEs in GCA.
Abstract

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...